Acta neurochirurgica · 2026
Patient-reported headache before and after surgery for pituitary adenomas: a longitudinal single-centre study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Strand Per Sveino, Richoz Benjamin Minh-van, Sagberg Lisa Millgård, Solheim Ole
Аннотация
INTRODUCTION: To what extent pituitary adenomas cause headache is controversial and the impact of transsphenoidal surgery on headache remains uncertain.
METHODS: We conducted a prospective, single-centre study of patients undergoing surgery for pituitary adenomas between 2014 and 2024. Headache was assessed using the EORTC QLQ-BN20 module, question four, at baseline, one month, and six months postoperatively. Demographic, clinical, and surgical data were analysed for associations with headache outcomes.
RESULTS: Of 207 eligible patients, 134 completed all assessments (63% male; median age 55 years). Preoperatively, 50% reported no headache, 33% a little, 8% quite a bit, and 9% very much headache. Headache was more common in females, but there was no relation to tumour related factors. At one month, 31% improved, 52% remained unchanged, and 16% worsened. At six months, 34% improved, 56% remained unchanged, and had 10% worsened compared to preoperatively. Among patients with preoperative headache (n = 67), 52% reported improvement at one month and 55% at six months. Among patients with no headache preoperatively, 25% and 12% reported having headache at one and six months, respectively. No demographic, tumour-related, or perioperative variables were significantly associated with headache change.
CONCLUSION: In this prospective longitudinal study, approximately half of patients with preoperative headache reported improvement following pituitary surgery, while a minority experienced worsening. No clear clinical predictors of headache before surgery or outcome after surgery were identified, suggesting a multifactorial nature of headache in patients with pituitary adenomas.
METHODS: We conducted a prospective, single-centre study of patients undergoing surgery for pituitary adenomas between 2014 and 2024. Headache was assessed using the EORTC QLQ-BN20 module, question four, at baseline, one month, and six months postoperatively. Demographic, clinical, and surgical data were analysed for associations with headache outcomes.
RESULTS: Of 207 eligible patients, 134 completed all assessments (63% male; median age 55 years). Preoperatively, 50% reported no headache, 33% a little, 8% quite a bit, and 9% very much headache. Headache was more common in females, but there was no relation to tumour related factors. At one month, 31% improved, 52% remained unchanged, and 16% worsened. At six months, 34% improved, 56% remained unchanged, and had 10% worsened compared to preoperatively. Among patients with preoperative headache (n = 67), 52% reported improvement at one month and 55% at six months. Among patients with no headache preoperatively, 25% and 12% reported having headache at one and six months, respectively. No demographic, tumour-related, or perioperative variables were significantly associated with headache change.
CONCLUSION: In this prospective longitudinal study, approximately half of patients with preoperative headache reported improvement following pituitary surgery, while a minority experienced worsening. No clear clinical predictors of headache before surgery or outcome after surgery were identified, suggesting a multifactorial nature of headache in patients with pituitary adenomas.